BAROSTIM NEO System in the Treatment of Heart Failure

NAUnknownINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

August 11, 2021

Conditions
Heart Failure
Interventions
DEVICE

BAROSTIM NEO System

DRUG

Medical Management

Trial Locations (30)

10967

Vivantes Hospital Berlin, Berlin

16321

Immanuel Hospital Bernau-Heart Center Brandenburg, Bernau

20089

Istituto Clinico Humanitas, Rozzano

20099

Klinik St. Georg, Hamburg, Hamburg

20149

Istituto Scientifico San Luca, Milan

20246

University Heart Center Hamburg, Hamburg

21465

Reinbek Hospital, St. Adolf-Stift, Reinbek

24105

University Hospital of Schleswig-Holstein, Kiel Campus, Kiel

24128

Azienda Ospedaliera Spedali Riuniti Di Bergamo, Bergamo

26133

Oldenburg Hospital, Oldenburg

30625

Medizinische Hochschule Hannover, Hanover

31073

CHU de Toulouse, Toulouse

35033

CHU de Rennes, Rennes

35392

University Hospital Giessen, Giessen

37075

Georg August University - Goettingen, Göttingen

41464

Lukas Hospital Neuss, Neuss

45122

University Hospital Essen, Essen

50134

Azienda Ospedaliero - Universitaria Careggi, Florence

50937

University Hospital Cologne, Cologne

58515

Klinikum Ludenscheid, Lüdenscheid

60126

Azienda Ospedaliero Universitaria Opedali, Ancona

60389

CVC Frankfurt, Frankfurt

68167

University Hospital Mannheim, Mannheim

590347

CHRU de Lille, Lille

T2N 4Z6

University of Calgary, Calgary

T6G 2B7

University of Alberta - Edmonton, Edmonton

V6Z 1Y6

University of British Columbia, Vancouver

R2H 2A6

St. Boniface Hospital, Winnipeg

H1T 1C8

Montreal Heart Institute, Montreal

04129

Klinikum St. Georg Leipzig, Leipzig

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CVRx, Inc.

INDUSTRY

NCT01471860 - BAROSTIM NEO System in the Treatment of Heart Failure | Biotech Hunter | Biotech Hunter